TY - JOUR T1 - Intentions to participate in cervical and colorectal cancer screening during the COVID-19 pandemic: a mixed-methods study JF - medRxiv DO - 10.1101/2021.07.20.21260558 SP - 2021.07.20.21260558 AU - Rebecca Wilson AU - Harriet Quinn-Scoggins AU - Yvonne Moriarty AU - Jacqueline Hughes AU - Mark Goddard AU - Rebecca Cannings-John AU - Victoria Whitelock AU - Katriina L Whitaker AU - Detelina Grozeva AU - Julia Townson AU - Kirstie Osborne AU - Stephanie Smits AU - Michael Robling AU - Julie Hepburn AU - Graham Moore AU - Ardiana Gjini AU - Kate Brain AU - Jo Waller Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/07/22/2021.07.20.21260558.abstract N2 - Worldwide, cancer screening faced significant disruption in 2020 due to the COVID-19 pandemic. If this has led to changes in public attitudes towards screening and reduced intention to participate, there is a risk of long-term adverse impact on cancer outcomes. In this study, we examined previous participation and future intentions to take part in cervical and colorectal cancer (CRC) screening following the first national lockdown in the UK.Overall, 7543 adults were recruited to a cross-sectional online survey in August-September 2020. Logistic regression analyses were used to identify correlates of strong screening intentions among 2,319 participants eligible for cervical screening and 2,502 eligible for home-based CRC screening. Qualitative interviews were conducted with a sub-sample of 30 participants. Verbatim transcripts were analysed thematically.Of those eligible, 74% of survey participants intended to attend cervical screening and 84% intended to complete home-based CRC screening when next invited. Thirty percent and 19% of the cervical and CRC samples respectively said they were less likely to attend a cancer screening appointment now than before the pandemic. Previous non-participation was the strongest predictor of low intentions for cervical (aOR 26.31, 95% CI: 17.61-39.30) and CRC (aOR 67.68, 95% CI: 33.91-135.06) screening. Interview participants expressed concerns about visiting healthcare settings but were keen to participate when screening programmes resumed.Intentions to participate in future screening were high and strongly associated with previous engagement in both programmes. As screening services recover, it will be important to monitor participation and to ensure people feel safe to attend.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialISRCTN17782018Clinical Protocols https://osf.io/ydp9r/ Funding StatementEconomic and Social Research Council as part of UK Research and Innovations Rapid Response to COVID-19 (ES/V00591X/1). The funders had no role in the design, conduct or analyses of this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was granted by the School of Medicine Research Ethics Committee, Cardiff University (ref 20.68).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDe-identified participant data will be made available to the scientific community with as few restrictions as feasible, whilst retaining exclusive use until the publication of major outputs. Data will be available via the corresponding author.CABSCancer Attitudes and Behaviour StudyCRCcolorectal canceraORAdjusted odds ratioGPGeneral Practitioner ER -